Clinical trials
Phase 2 Encephalitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| St. Joseph's Hospital and Medical Center, Phoenix | 2 |
| Arialys Australia Pty Ltd | 1 |
| Bavarian Nordic | 1 |
| Elisabethinen Hospital | 1 |
| Jena University Hospital | 1 |
| MacroGenics | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Sanofi | 1 |
| Tel-Aviv Sourasky Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Encephalitis | 13 |
| Autoimmune Diseases of the Nervous System | 3 |
| Alzheimer Disease | 2 |
| Cognitive Dysfunction | 2 |
| Plaque, Amyloid | 2 |
| Virus Diseases | 2 |
| West Nile Fever | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Alphavirus Infections | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.